研究主要终点是客观缓解率，治疗后经受完全或部分癌症皱缩或消失患者的百分率。
The study’s primary endpoint was objective response rate, the percentage of patients who experienced complete or partial cancer shrinkage or disappearance after treatment.
主要研究终点为总缓解率(ORR)，采用评价标准为RECIST 1.1。
The primary end point was overall response rate (ORR) per investigator assessment (RECIST 1.1).
主要观察终点为客观有效率、临床获益率、毒副反应发生率。
The primary end points were the overall rate of objective response, disease control rate and adverse effects rate.
主要 终点则为出现病毒失败患者的百分率。
The primary end point was the percentage of patients who experienced virologic failure.
主要终点是总生存率(OS)。
结果易化pci治疗与直接pci治疗比较，术中“罪犯”血管开通率、30天内主要终点事件发生率和出血事件发生率之间差异无显著性。
Results Compared with direct emergency PCI, criminal vascular patency rate, incidence of MACE within 30 day and bleeding events have not significantly different in facilitated emergency PCI group.
结果易化pci治疗与直接pci治疗比较，术中“罪犯”血管开通率、30天内主要终点事件发生率和出血事件发生率之间差异无显著性。
Results Compared with direct emergency PCI, criminal vascular patency rate, incidence of MACE within 30 day and bleeding events have not significantly different in facilitated emergency PCI group.
应用推荐